The heart closure devices market size has grown rapidly in recent years. It will grow from $3.08 billion in 2025 to $3.46 billion in 2026 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increasing prevalence of congenital heart defects, expansion of catheterization laboratories, growing adoption of minimally invasive cardiac treatments, rising awareness of structural heart conditions, availability of advanced imaging guidance.
The heart closure devices market size is expected to see rapid growth in the next few years. It will grow to $5.42 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to increasing demand for catheter-based cardiac therapies, rising investments in structural heart disease treatment, expansion of specialized cardiac centers, growing focus on reducing surgical risks, technological advancements in closure device design. Major trends in the forecast period include increasing adoption of transcatheter heart closure procedures, rising demand for minimally invasive cardiac devices, growing use of nitinol-based closure systems, expansion of structural heart intervention programs, enhanced focus on procedural safety and efficacy.
The increasing incidence of cardiovascular diseases (CVDs) is expected to drive the growth of the heart closure devices market. The rise in CVDs is attributed to factors such as aging, unhealthy lifestyle choices, genetic predisposition, and a higher prevalence of risk factors such as hypertension, diabetes, and obesity. Heart closure devices play a crucial role in minimizing complications caused by congenital heart defects by closing abnormal openings in the heart with minimal invasiveness, improving blood flow, and preventing further health issues. For instance, in May 2024, the Singapore Heart Foundation reported that cardiovascular diseases accounted for 26,885 deaths in 2023, with ischemic heart disease alone causing 5,302 deaths, showing a slight increase from the previous year. This growing incidence of cardiovascular diseases is driving the demand for heart closure devices market.
Major players in the heart closure devices market are prioritizing technological innovations, such as low-profile, ergonomic surgical LAA devices with continuous closing force mechanisms, to improve procedural precision, visibility, and ease of use for physicians while enhancing patient outcomes. Low-profile surgical LAA devices enable safe and effective closure of the left atrial appendage, offering optimal tissue compression, simplified single-handed placement, and improved access during minimally invasive procedures. For example, in August 2024, AtriCure, Inc., a US-based cardiac surgical solutions company, treated its first patient with the AtriClip FLEX-Mini device, the smallest-profile surgical LAA device available. Building on the established AtriClip platform, the device features a fully enclosed design with parallel beams that provide continuous closing force, enhanced visibility, and an ergonomic handle for single-handed placement, helping physicians deliver precise, safe, and efficient LAA management for patients with atrial fibrillation.
In November 2023, Johnson & Johnson MedTech, a US-based medical device company, acquired Laminar Inc. for $400 million. This acquisition enhances Johnson & Johnson MedTech's product offerings in cardiac arrhythmia treatment, strengthens its market presence in left atrial appendage elimination devices, and enables innovation in stroke prevention solutions for patients with non-valvular atrial fibrillation. Laminar Inc. is a US-based manufacturer specializing in heart closure devices.
Major companies operating in the heart closure devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Lepu Medical Technology Ltd., Terumo Corporation, Edwards Lifesciences, Teleflex Incorporated, Merit Medical Systems Inc., Cordis Corporation, AtriCure Inc., Lifetech Scientific Corp., Sahajanand Medical Technologies, W. L. Gore And Associates Inc., Occlutech GmbH, NMT Medical Inc., Sorin Group Italia S.p.A., Vivasure Medical Limited, B Braun Interventional Systems, HeartStitch Inc., MicroPort Scientific Corporation.
North America was the largest region in the heart closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the heart closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the heart closure devices market by increasing costs of imported nitinol materials, delivery catheters, imaging-compatible components, and precision manufacturing equipment. Cardiac hospitals and catheterization laboratories in North America and Europe are most affected due to reliance on imported high-performance devices, while Asia-Pacific faces higher production costs for export markets. These tariffs are elevating device prices and influencing procurement decisions. However, they are also supporting domestic device manufacturing, regional supply chain development, and innovation in cost-optimized minimally invasive cardiac solutions.
The heart closure devices market research report is one of a series of new reports that provides heart closure devices market statistics, including heart closure devices industry global market size, regional shares, competitors with a heart closure devices market share, detailed heart closure devices market segments, market trends and opportunities, and any further data you may need to thrive in the heart closure devices industry. This heart closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Heart closure devices are sophisticated medical instruments designed to close holes or openings in the heart, often resulting from congenital defects or surgical procedures. These devices are used to treat conditions such as atrial septal defects (ASD), patent foramen ovale (PFO), and other structural heart issues. Typically, they are delivered through catheter-based procedures, providing a safer alternative to open-heart surgery.
The main types of heart closure devices include atrial septal defect (ASD) closure devices, ventricular septal defect (VSD) closure devices, patent foramen ovale (PFO) closure devices, left atrial appendage (LAA) closure devices, and others. ASD closure devices are implants used to seal abnormal openings in the septum between the heart's upper chambers and are usually deployed through minimally invasive catheter-based procedures. These devices are commonly made from materials such as nitinol, stainless steel, and other substances. Delivery methods include both transcatheter and surgical approaches, and these devices are utilized in various healthcare settings such as hospitals, ambulatory surgical centers (ASCs), and cardiac catheterization laboratories.
The heart closure devices market consists of sales of septal occluders, embolic protection devices, valvular closure devices, balloon occlusion devices, and transcatheter closure devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The heart closure devices market size is expected to see rapid growth in the next few years. It will grow to $5.42 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to increasing demand for catheter-based cardiac therapies, rising investments in structural heart disease treatment, expansion of specialized cardiac centers, growing focus on reducing surgical risks, technological advancements in closure device design. Major trends in the forecast period include increasing adoption of transcatheter heart closure procedures, rising demand for minimally invasive cardiac devices, growing use of nitinol-based closure systems, expansion of structural heart intervention programs, enhanced focus on procedural safety and efficacy.
The increasing incidence of cardiovascular diseases (CVDs) is expected to drive the growth of the heart closure devices market. The rise in CVDs is attributed to factors such as aging, unhealthy lifestyle choices, genetic predisposition, and a higher prevalence of risk factors such as hypertension, diabetes, and obesity. Heart closure devices play a crucial role in minimizing complications caused by congenital heart defects by closing abnormal openings in the heart with minimal invasiveness, improving blood flow, and preventing further health issues. For instance, in May 2024, the Singapore Heart Foundation reported that cardiovascular diseases accounted for 26,885 deaths in 2023, with ischemic heart disease alone causing 5,302 deaths, showing a slight increase from the previous year. This growing incidence of cardiovascular diseases is driving the demand for heart closure devices market.
Major players in the heart closure devices market are prioritizing technological innovations, such as low-profile, ergonomic surgical LAA devices with continuous closing force mechanisms, to improve procedural precision, visibility, and ease of use for physicians while enhancing patient outcomes. Low-profile surgical LAA devices enable safe and effective closure of the left atrial appendage, offering optimal tissue compression, simplified single-handed placement, and improved access during minimally invasive procedures. For example, in August 2024, AtriCure, Inc., a US-based cardiac surgical solutions company, treated its first patient with the AtriClip FLEX-Mini device, the smallest-profile surgical LAA device available. Building on the established AtriClip platform, the device features a fully enclosed design with parallel beams that provide continuous closing force, enhanced visibility, and an ergonomic handle for single-handed placement, helping physicians deliver precise, safe, and efficient LAA management for patients with atrial fibrillation.
In November 2023, Johnson & Johnson MedTech, a US-based medical device company, acquired Laminar Inc. for $400 million. This acquisition enhances Johnson & Johnson MedTech's product offerings in cardiac arrhythmia treatment, strengthens its market presence in left atrial appendage elimination devices, and enables innovation in stroke prevention solutions for patients with non-valvular atrial fibrillation. Laminar Inc. is a US-based manufacturer specializing in heart closure devices.
Major companies operating in the heart closure devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Lepu Medical Technology Ltd., Terumo Corporation, Edwards Lifesciences, Teleflex Incorporated, Merit Medical Systems Inc., Cordis Corporation, AtriCure Inc., Lifetech Scientific Corp., Sahajanand Medical Technologies, W. L. Gore And Associates Inc., Occlutech GmbH, NMT Medical Inc., Sorin Group Italia S.p.A., Vivasure Medical Limited, B Braun Interventional Systems, HeartStitch Inc., MicroPort Scientific Corporation.
North America was the largest region in the heart closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the heart closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the heart closure devices market by increasing costs of imported nitinol materials, delivery catheters, imaging-compatible components, and precision manufacturing equipment. Cardiac hospitals and catheterization laboratories in North America and Europe are most affected due to reliance on imported high-performance devices, while Asia-Pacific faces higher production costs for export markets. These tariffs are elevating device prices and influencing procurement decisions. However, they are also supporting domestic device manufacturing, regional supply chain development, and innovation in cost-optimized minimally invasive cardiac solutions.
The heart closure devices market research report is one of a series of new reports that provides heart closure devices market statistics, including heart closure devices industry global market size, regional shares, competitors with a heart closure devices market share, detailed heart closure devices market segments, market trends and opportunities, and any further data you may need to thrive in the heart closure devices industry. This heart closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Heart closure devices are sophisticated medical instruments designed to close holes or openings in the heart, often resulting from congenital defects or surgical procedures. These devices are used to treat conditions such as atrial septal defects (ASD), patent foramen ovale (PFO), and other structural heart issues. Typically, they are delivered through catheter-based procedures, providing a safer alternative to open-heart surgery.
The main types of heart closure devices include atrial septal defect (ASD) closure devices, ventricular septal defect (VSD) closure devices, patent foramen ovale (PFO) closure devices, left atrial appendage (LAA) closure devices, and others. ASD closure devices are implants used to seal abnormal openings in the septum between the heart's upper chambers and are usually deployed through minimally invasive catheter-based procedures. These devices are commonly made from materials such as nitinol, stainless steel, and other substances. Delivery methods include both transcatheter and surgical approaches, and these devices are utilized in various healthcare settings such as hospitals, ambulatory surgical centers (ASCs), and cardiac catheterization laboratories.
The heart closure devices market consists of sales of septal occluders, embolic protection devices, valvular closure devices, balloon occlusion devices, and transcatheter closure devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Heart Closure Devices Market Characteristics
3. Heart Closure Devices Market Supply Chain Analysis
4. Global Heart Closure Devices Market Trends and Strategies
5. Heart Closure Devices Market Analysis of End Use Industries
7. Global Heart Closure Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Heart Closure Devices Total Addressable Market (TAM) Analysis for the Market
9. Heart Closure Devices Market Segmentation
10. Heart Closure Devices Market Regional and Country Analysis
11. Asia-Pacific Heart Closure Devices Market
12. China Heart Closure Devices Market
13. India Heart Closure Devices Market
14. Japan Heart Closure Devices Market
15. Australia Heart Closure Devices Market
16. Indonesia Heart Closure Devices Market
17. South Korea Heart Closure Devices Market
18. Taiwan Heart Closure Devices Market
19. South East Asia Heart Closure Devices Market
20. Western Europe Heart Closure Devices Market
21. UK Heart Closure Devices Market
22. Germany Heart Closure Devices Market
23. France Heart Closure Devices Market
24. Italy Heart Closure Devices Market
25. Spain Heart Closure Devices Market
26. Eastern Europe Heart Closure Devices Market
27. Russia Heart Closure Devices Market
28. North America Heart Closure Devices Market
29. USA Heart Closure Devices Market
30. Canada Heart Closure Devices Market
31. South America Heart Closure Devices Market
32. Brazil Heart Closure Devices Market
33. Middle East Heart Closure Devices Market
34. Africa Heart Closure Devices Market
36. Heart Closure Devices Market Competitive Landscape and Company Profiles
37. Heart Closure Devices Market Other Major and Innovative Companies
40. Heart Closure Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Heart Closure Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses heart closure devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for heart closure devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The heart closure devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Atrial Septal Defect (ASD) Closure Devices; Ventricular Septal Defect (VSD) Closure Devices; Patent Foramen Ovale (PFO) Closure Devices; Left Atrial Appendage (LAA) Closure Devices; Other Products2) By Material: Nitinol-Based Devices; Stainless Steel Devices; Other Materials
3) By Mode of Delivery: Transcatheter Delivery; Surgical Delivery
4) By End Use: Hospitals; Ambulatory Surgical Centers (ASCs); Cardiac Catheterization Laboratories; Other End Uses
Subsegments:
1) By Atrial Septal Defect (ASD) Closure Devices: Self-expanding Occluders; Balloon-expandable Occluders; Other ASD Closure Devices2) By Ventricular Septal Defect (VSD) Closure Devices: Transcatheter VSD Closure Devices; Surgical VSD Closure Devices; Other VSD Closure Devices
3) By Patent Foramen Ovale (PFO) Closure Devices: Double-Disc Occluders; Single-Disc Occluders; Other PFO Closure Devices
4) By Left Atrial Appendage (LAA) Closure Devices: LAA Occluders; LAA Clip Systems; Other LAA Closure Devices
5) By Other Products: Septal Defect Closure Devices; Endovascular Closure Devices; Other Specialty Closure Devices
Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corp.; Lepu Medical Technology Ltd.; Terumo Corporation; Edwards Lifesciences; Teleflex Incorporated; Merit Medical Systems Inc.; Cordis Corporation; AtriCure Inc.; Lifetech Scientific Corp.; Sahajanand Medical Technologies; W. L. Gore And Associates Inc.; Occlutech GmbH; NMT Medical Inc.; Sorin Group Italia S.p.A.; Vivasure Medical Limited; B Braun Interventional Systems; HeartStitch Inc.; MicroPort Scientific Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Heart Closure Devices market report include:- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corp.
- Lepu Medical Technology Ltd.
- Terumo Corporation
- Edwards Lifesciences
- Teleflex Incorporated
- Merit Medical Systems Inc.
- Cordis Corporation
- AtriCure Inc.
- Lifetech Scientific Corp.
- Sahajanand Medical Technologies
- W. L. Gore And Associates Inc.
- Occlutech GmbH
- NMT Medical Inc.
- Sorin Group Italia S.p.A.
- Vivasure Medical Limited
- B Braun Interventional Systems
- HeartStitch Inc.
- MicroPort Scientific Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.46 Billion |
| Forecasted Market Value ( USD | $ 5.42 Billion |
| Compound Annual Growth Rate | 11.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
